Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
18.92
-2.62 (-12.16%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Cidara Therapeutics Statistics

Total Valuation

CDTX has a market cap or net worth of $207.24 million. The enterprise value is $20.99 million.

Market Cap 207.24M
Enterprise Value 20.99M

Important Dates

The last earnings date was Thursday, March 6, 2025, after market close.

Earnings Date Mar 6, 2025
Ex-Dividend Date n/a

Share Statistics

CDTX has 10.95 million shares outstanding. The number of shares has increased by 45.26% in one year.

Current Share Class 10.95M
Shares Outstanding 10.95M
Shares Change (YoY) +45.26%
Shares Change (QoQ) +48.97%
Owned by Insiders (%) 1.03%
Owned by Institutions (%) 14.21%
Float 4.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 94.22
Forward PS n/a
PB Ratio 1.27
P/TBV Ratio 1.27
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 16.46
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.02.

Current Ratio 4.25
Quick Ratio 3.86
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -219.59% and return on invested capital (ROIC) is -69.72%.

Return on Equity (ROE) -219.59%
Return on Assets (ROA) -40.46%
Return on Invested Capital (ROIC) -69.72%
Return on Capital Employed (ROCE) -55.20%
Revenue Per Employee $33,553
Profits Per Employee -$4.47M
Employee Count 38
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.83% in the last 52 weeks. The beta is 0.88, so CDTX's price volatility has been lower than the market average.

Beta (5Y) 0.88
52-Week Price Change +2.83%
50-Day Moving Average 21.79
200-Day Moving Average 16.47
Relative Strength Index (RSI) 37.05
Average Volume (20 Days) 147,915

Short Selling Information

The latest short interest is 289,926, so 2.65% of the outstanding shares have been sold short.

Short Interest 289,926
Short Previous Month 237,747
Short % of Shares Out 2.65%
Short % of Float 6.35%
Short Ratio (days to cover) 2.86

Income Statement

In the last 12 months, CDTX had revenue of $1.28 million and -$169.83 million in losses. Loss per share was -$26.75.

Revenue 1.28M
Gross Profit -70.60M
Operating Income -91.22M
Pretax Income -36.02M
Net Income -169.83M
EBITDA -91.07M
EBIT -91.22M
Loss Per Share -$26.75
Full Income Statement

Balance Sheet

The company has $189.83 million in cash and $3.58 million in debt, giving a net cash position of $186.25 million or $17.00 per share.

Cash & Cash Equivalents 189.83M
Total Debt 3.58M
Net Cash 186.25M
Net Cash Per Share $17.00
Equity (Book Value) 163.31M
Book Value Per Share 14.92
Working Capital 161.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$176.53 million and capital expenditures -$129,000, giving a free cash flow of -$176.66 million.

Operating Cash Flow -176.53M
Capital Expenditures -129,000
Free Cash Flow -176.66M
FCF Per Share -$16.13
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -7,154.43%
Pretax Margin -13,356.16%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -45.26%
Shareholder Yield -45.26%
Earnings Yield -81.95%
FCF Yield -85.25%

Analyst Forecast

The average price target for CDTX is $38.00, which is 100.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target $38.00
Price Target Difference 100.85%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 150.22%
EPS Growth Forecast (5Y) -50.02%
Stock Forecasts

Stock Splits

The last stock split was on April 24, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date Apr 24, 2024
Split Type Reverse
Split Ratio 0.05:1

Scores

CDTX has an Altman Z-Score of -3.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.45
Piotroski F-Score 1